News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
261 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19288)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Bio NC
TransEnterix Announces LSU Health Completes Purchase of Senhance Surgical System
TransEnterix, Inc. announced that LSU Health completed the purchase of the Company’s Senhance™ Surgical System.
May 31, 2018
·
5 min read
Business
Canopy Rivers Announces Board of Directors and Key Additions to Management Team
Canopy Rivers Corporation (“Canopy Rivers”, or the “Company”) is pleased to announce its newly appointed, majority independent Board of Directors, as well as a number of strategic appointments to its management team.
May 31, 2018
·
11 min read
BioMidwest
Centegra expands usage of enTouch network to all discharges and Medicaid population
Centegra Health System has announced that they are expanding the usage of enTouch to manage all discharges from the health system.
May 31, 2018
·
2 min read
BioMidwest
Blue Cross Blue Shield Association Warns of Increase in Melanoma Diagnoses
Prevalence of melanoma diagnoses increased 7 percent over a four-year span, according to information released by the Blue Cross Blue Shield Association (BCBSA)'s Health of America Report.
May 31, 2018
·
4 min read
Biotech Beach
Good Samaritan Hospital Receives Get With The Guidelines-Stroke Silver Plus Quality Achievement Award
Good Samaritan Hospital has received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Silver Plus Quality Achievement Award.
May 31, 2018
·
2 min read
FDA
Encision Inc. Applauds the FDA’s Safety Communication On The Dangers Of Monopolar Electrosurgery
Encision Inc. applauded the FDA’s issuance of a safety communication.
May 31, 2018
·
3 min read
Genetown
Recovery Centers of America-Westminster Expands to 64 Beds to Meet Increasing Demand for Substance Use Disorder
Recovery Centers of America (RCA) announced that its Westminster, Mass., facility has expanded the number of Clinical Support Services (CSS) beds from 32 to 48.
May 31, 2018
·
3 min read
Genetown
Proteostasis Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
Proteostasis Therapeutics, Inc. announced that Po-Shun Lee, M.D., the Company’s Chief Medical Officer, will present at the Jefferies 2018 Global Healthcare Conference.
May 31, 2018
·
3 min read
Drug Development
Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Curis, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of fimepinostat in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy.
May 31, 2018
·
3 min read
Policy
Sarissa Capital Issues Statement On Ironwood Pharmaceuticals
Sarissa Capital Management LP today made the following statement regarding Ironwood Pharmaceuticals, Inc.
May 31, 2018
·
2 min read
Previous
3 of 27
Next